LeaderPortfolio
Michel
Willy Michel
Rank #808
SWITZERLANDHealthcareMedical devices

Willy Michel

Net Worth
$5.084B
+0.79% (24h)
Willy Michel, born in Switzerland on April 29, 1947, is a highly successful entrepreneur in the medical devices industry. He is best known as the founder of Ypsomed Selfcare Solutions, a company specializing in injection systems and infusion pumps. Michel's career highlights include founding Ypsomed and growing it into a global leader in healthcare, which has significantly contributed to his $4.3 billion net worth. He is also recognized for his art collection and philanthropic endeavors. Michel's main source of wealth comes from medical devices, and he is a significant shareholder in Ypsomed, holding a 71% stake.

How to read Willy Michel's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Willy Michel, we anchor the narrative to Medical devices and Medical devices, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $5.084B alongside global rank #808, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (SWITZERLAND) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life

Wilhelm "Willy" Michel was born on April 29, 1947, in Burgdorf, Switzerland. Growing up in a prominent Swiss family, he developed a strong work ethic early in his life. His father was a successful businessman, and his mother was a homemaker.

Rise to Success

Michel's career began with a foundation in pharmaceutical consulting. He gained extensive experience in development, sales, and marketing within several industrial and pharmaceutical companies. In 1984, he founded Disetronic Holding AG with his brother, focusing on medical infusion systems. The company's success continued, and by 2000, Disetronic had over 1,021 employees and generated substantial sales. In 2003, the company was split and a portion was sold to Roche. Willy Michel then bought back the injection business and rebranded it as Ypsomed Selfcare Solutions.

Key Business Strategies

A key strategy was his focus on precision engineering and microtechnology manufacturing techniques, leading to the development of reliable insulin pumps and advanced medical devices. Michel retained controlling shareholder status with a combined 71% of the shares, giving him significant control over the company's operations and decision-making. The company's global expansion to over 80 countries is a testament to successful strategies.

Philanthropy

Willy Michel is known for his philanthropic efforts, including significant donations to various charitable organizations and educational institutions. Michel founded an art museum with his collection of Franz Gertsch portraits.

Career Timeline

2006

Honorary Doctorate

Awarded an honorary doctorate (Dr. h. c.) by the Economic and Social Science Faculty of the University of Bern.

2005

Master Entrepreneur Award

Named Master Entrepreneur by Ernst & Young Switzerland.

2003

Sold part of Disetronic and Created Ypsomed

Sold part of Disetronic to Roche and formed Ypsomed.

1984

Founded Disetronic

Founded Disetronic Holding AG with his brother.

1947

Born

Wilhelm "Willy" Michel was born in Switzerland.

Philanthropic Impact

CharityUndisclosed

Various Charitable Organizations and Educational Institutions

Made significant donations.

Key Business Ventures & Holdings

CompanyStakeValue
Ypsomed Holding AG71.50%

Net Worth History

In-Depth Analysis

Early Life

Wilhelm "Willy" Michel was born on April 29, 1947, in Burgdorf, Switzerland. Growing up in a prominent Swiss family, he developed a strong work ethic early in his life. His father was a successful businessman, and his mother was a homemaker.

Rise to Success

Michel's career began with a foundation in pharmaceutical consulting. He gained extensive experience in development, sales, and marketing within several industrial and pharmaceutical companies. In 1984, he founded Disetronic Holding AG with his brother, focusing on medical infusion systems. The company's success continued, and by 2000, Disetronic had over 1,021 employees and generated substantial sales. In 2003, the company was split and a portion was sold to Roche. Willy Michel then bought back the injection business and rebranded it as Ypsomed Selfcare Solutions.

Key Business Strategies

A key strategy was his focus on precision engineering and microtechnology manufacturing techniques, leading to the development of reliable insulin pumps and advanced medical devices. Michel retained controlling shareholder status with a combined 71% of the shares, giving him significant control over the company's operations and decision-making. The company's global expansion to over 80 countries is a testament to successful strategies.

Philanthropy

Willy Michel is known for his philanthropic efforts, including significant donations to various charitable organizations and educational institutions. Michel founded an art museum with his collection of Franz Gertsch portraits.

Data Sources & Methodology

Figures for Willy Michel are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.